-
Mashup Score: 0Space Unicorn - 11 hour(s) ago
Parry Gripp · Parry Gripp Mega-Party (2008 – 2012) · Song · 2013
Source: open.spotify.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 11Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis: - 8 day(s) ago
AbstractBackgroundCurrent guidelines recommend a strategy of clinical surveillance (CS) for patients with asymptomatic severe aortic stenosis (AS) and normal left ventricular ejection fraction.Obje…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis | Journal of the American College of Cardiology Congrats to all on this collaborative Meta-Analysis of the 4 trial groups! https://t.co/i9hDW2IeGh
-
-
Mashup Score: 30
The dedicated device can lacerate bioprosthetic leaflets poised to cause coronary obstruction—and does it quickly.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI https://t.co/i01J0iRyVs Congratulation to all investigators of ShortCut @Pi_Cardia study! The field of Leaflet Modification just got better! @PCRonline @crfheart @DrTomWaggoner @didier_tchetche
-
-
Mashup Score: 6Options to Improve Quality of Life for Aortic Stenosis: “No Decision About Me, Without Me” - 2 year(s) ago
Section snippetsFunding Support and Author DisclosuresDr Coylewright has received research funding from Edwards LifeSciences and Boston Scientific; has received honoraria from Edwards LifeSciences, Boston Scientific, Medtronic, and Occlutech; and leads the global Eligibility Review Committee for the EXPAND II trial. Dr Januzzi is a Trustee of the American College of Cardiology; is a board member…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
Great editorial by @MCoylewright @JJheart_doc @mszerlip in @JACCJournals ahead of @ACCinTouch “No decision about me, without me” Thanks for your great insight! https://t.co/EyiODBHvhl @arnoldgehrke @djc795 @PPibarot @hahn_rt @tavrkapadia @TAVRBot @STS_CTsurgery https://t.co/er4MdJldlg
-
-
Mashup Score: 6Please wait whilst we redirect you - 2 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
Now Published! Our analysis from the PARTNER trials on the importance of Cardiac Damage and QoL before and after AVR. Thanks to all co-authors and collaborators! @djc795 @PPibarot @tavrkapadia @VinodThourani @hahn_rt @JACCJournals @ACCinTouch https://t.co/Fzrt3KfkeZ
-
-
Mashup Score: 3First US Patient Successfully Treated with ShortCut(TM) - 2 year(s) ago
First Dedicated Leaflet Splitting Device To Facilitate Valve-in-Valve Procedures REHOVOT, ISRAEL / ACCESSWIRE / December 19, 2022 / Pi-Cardia Ltd., a global leader in the development of non-implant, catheter-based, leaflet modification solutions for treating heart valves, announced today that the first patient in the United States has been successfully treated with ShortCut™ – the world’s first…
Source: www.accesswire.comCategories: Cardiologists, Latest HeadlinesTweet-
First US Patient Successfully Treated with ShortCut(TM) https://t.co/PfIvdu7cfF Excited to share that @AtlanticHealth @morristownheart team did the First leaflet splitting using @Pi_Cardia Shortcut device in USA! Thanks to all and @benjaminseguy for his guidance! #TAVR @TAVRBot https://t.co/YvtiOUYjv2
-
-
Mashup Score: 2
Abstract Background The impact of aortic valve replacement (AVR) on progression/regression of extra-valvular cardiac damage and its association with subsequent prognosis is unknown. Objectives To d…
Categories: Cardiologists, Latest HeadlinesTweet-
Our new manuscript simultaneous publication in @JACCJournals with @PCRonline presentation. Thanks to all contributors and specifically @PPibarot and @djc795 https://t.co/mZuY0W4xua @hahn_rt @jeroenjbax1 @tavrkapadia @VinodThourani @LindaGillamMD @MartyMleon @BjornRedfors https://t.co/4vLVtYjfOt
-
-
Mashup Score: 2
Background: Severe coronary artery calcification has been associated with stent underexpansion, procedural complications, and increased rates of early…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
Just published online!@AmericanHeartJ https://t.co/QvqSSC71SK Design paper of the @ECLIPSE_Trial @ajaykirtane @GreggWStone @Kandzari @mwkrucoff @ehrin_armstrong @ziadalinyc @MaeharaAkiko @csi360 2000 pts randomized trial; PCI of severely calcified lesion: OAS vs. balloon
-
-
Mashup Score: 2
This new percutaneous adjunctive CBOT combined with the Prostar PCD resulted in controlled, safe, and successful percutaneous closure in most patients after TAVI.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
@GilbertTangMD @yourheartdoc1 @HeartValveCntr @tnazifMD @igeorge1975 @djc795 @KHERA_MD @JasonFoerst @ZeroTLR We always do. Saved transfusion, saved annoying bleeds/oozing, and improved ambulation time. Bleeding are unpredictable, and sometime stenosis could be resolved. https://t.co/ijT00WT2j0
-
-
Mashup Score: 4
This study may change the way we manage patients with moderate aortic stenosis and save lives.
Source: www.newswise.comCategories: Cardiologists, Latest HeadlinesTweet-
Atlantic Health System’s Morristown Medical Center Randomizes First Patient in World to New Study to Evaluate Treatment with TAVR for Moderate Aortic Stenosis https://t.co/GBQjdin9l7 Proud to be part of this great team!@AtlanticHealth @morristownheart @ACCinTouch @LindaGillamMD
-
https://t.co/PHWsYYBvM2